ARKO vs BABA

ARKO's Piotroski F-Score of 4/9 indicates weak financial health, signaling distress in operational efficiency and capital structure. The absence of an Altman Z-Score raises red flags for potential bankruptcy risk, especially given a dangerously high Debt/Equity ratio of 7.02. While the stock trades below its Graham Number ($2.85) and intrinsic value ($1.05), it is currently priced at $5.26—well above both, suggesting a significant premium driven by speculative growth expectations. Despite strong earnings surprises in recent quarters and a 'strong_buy' analyst consensus, the company exhibits negative revenue growth (-10.7% YoY), deteriorating profitability, and a high payout ratio of 80%, undermining sustainability. The technical trend is bearish (0/100), reinforcing downward momentum.

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.